On Wednesday, there was a hearing for a federal lawsuit led by Louisiana seeking to further restrict access to Mifepristone by asking the courts to stop the mailing of abortion medication.

Dozens of abortion clinics closed in the US after the Supreme Court Dobbs decision revoked the federal right to an abortion in June 2022 – mostly in states that enacted bans. But the churn has continued, leaving even states with some of the most protective abortion policies to do more with less.

In at least 70,000 cases in 21 states, parents were referred to law enforcement agencies over allegations of substance use during pregnancy, according to six years of state and federal data obtained and published for the first time by the Marshall Project.

According to an estimate by the Guttmacher Institute, nearly 200 anti-abortion bills have been introduced in 29 states.

Texas Attorney General Ken Paxton filed a lawsuit against a Delaware nurse practitioner for allegedly mailing abortion medication into Texas, violating the state’s abortion ban.

ProPublica’s reporting on the deaths of pregnant women living in states with abortion bans found that abortion bans generally do not include exceptions that cover high-risk pregnancies based on underlying health issues, and if they do, doctors do not use them.

After Louisiana Attorney General Liz Murrill sought to extradite a California doctor accused of violating Louisiana’s abortion laws on Tuesday, Governor Gavin Newsom refused to extradite the California doctor.

The increased use of abortion medication following the Supreme Court’s overturning of Roe v. Wade fueled a new wave of legal battles involving the regulation of Mifepristone.

The Senate failed to pass the Democrats’ multi-year clean extension of the health insurance subsidies or Republicans’ alternative plan that would have funneled money into health savings accounts and imposed new national restrictions on abortion and gender-affirming care.

On Tuesday, Florida and Texas filed a complaint against the Food and Drug Administration for acting unlawfully when it approved, then eased safety restrictions on, mifepristone.

A federal judge on Tuesday blocked the Trump administration from enforcing in 22 states a provision of Donald Trump’s signature tax and domestic policy bill that would deprive Planned Parenthood and local affiliates that perform abortions of Medicaid funding.

Physicians for Reproductive Health issued a groundbreaking research brief, “Cascading Harms: How Abortion Bans Lead to Discriminatory Care Across Medical Specialties.”

Senate Republicans say they’re open to extending a pot of Affordable Care Act funds that will expire at the end of the year – but only if Democrats acquiesce to stricter abortion restrictions on insurance plans.

Now, Democrats’ commanding victories in the 2025 elections have breathed new life into the [abortion rights] fight.

The U.S. Department of Health and Human Services’ Office of Population Affairs, which administers the Title X Family Planning Program, has been effectively shut down.

Pregnant women have reported bleeding, miscarriages, being shackled and other instances of medical neglect while in US immigration custody, according to a group of prominent civil rights organizations.

TThe decimation of the Department of Health and Human Services’ Office of Population Affairs — part of a larger effort by President Donald Trump to fire federal employees during the government shutdown — threatens a program that has existed for over 50 years .

The availability of abortion pills in states with bans on the procedure is facing a new challenge after Louisiana filed a lawsuit to curb mailing of the medication within its borders, claiming the process circumvents state law.

In the first two years after the U.S. Supreme Court overturned Roe v. Wade, prosecutors in 16 states charged more than 400 people with pregnancy-related crimes, new research released on Tuesday found.

Texas, Florida, and Louisiana are urging US District Judge Matthew Kacsmaryk of the Northern District of Texas to let them join Missouri v. FDA, a lawsuit by three other red states seeking to force the Food and Drug Administration to drop telemedicine access to the abortion medication mifepristone and further restrict its use.